OSI-774 (gefitinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OSI-774 (gefitinib), covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer [Phase 2]